A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 43 (11) , 803-810
- https://doi.org/10.1016/s0006-3223(98)00093-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosisPsychological Medicine, 1993
- Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophreniaSchizophrenia Research, 1991
- Schizophrenics Kill Themselves Too: A Review of Risk Factors for SuicideSchizophrenia Bulletin, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- Measurement of mood and affect in schizophrenic inpatientsAmerican Journal of Psychiatry, 1985
- The Causality of Depression in SchizophreniaThe British Journal of Psychiatry, 1983
- SCHIZOPHRENIA AS DOPAMINE-DEFICIENCY DISEASEThe Lancet, 1978
- A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophreniaPsychological Medicine, 1978